响应pH值的Janus类的高分子融合蛋白用于功能性蛋白质输送
Seah Ling Kuan1, David Y W Ng, Yuzhou Wu
1Institute of Organic Chemistry III, Macromolecular Chemistry, University of Ulm , Albert-Einstein-Allee 11, D-89081 Ulm, Germany.
Journal of the American Chemical Society
|October 26, 2013
概括
研究人员开发了一种新的方法,使用非共价固定平台创建类似于Janus的融合蛋白. 这些蛋白质可以穿越细胞膜,并在pH值变化时释放载荷,保持生物活性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 开发用于复杂蛋白质结构的受控组装方法对于生物应用至关重要.
- 刺激反应性蛋白质系统可以精确控制生物过程.
研究的目的:
- 为了创建一个简单的,非共价的固相固定平台,用于组装类似于Janus的超分子融合蛋白.
- 为了设计能够进行膜转移和控制货物释放的异构融合蛋白质.
主要方法:
- 使用化学后改造的载体蛋白 (DHSA) 与 (imino) 生物化货物蛋白融合.
- 在组装过程中使用avidin适配器进行高度的空间控制.
- 研究了衍生异构聚变蛋白质的特性,包括膜交叉和pH依赖解离.
主要成果:
- 成功组装了具有受控空间布局的雅努斯类超分子融合蛋白质.
- 证明异构融合蛋白可以穿越细胞膜.
- 展示了依赖于pH值的iminobiotin链接物的解离,释放活性载荷蛋白 (β-galactosidase和C. botulinum C2毒素酶子单元).
结论:
- 描述的平台可以创建具有刺激反应的,类似于Janus的超分子融合蛋白.
- 这种"混合匹配"策略为构建具有高结构定义和生物活性的复杂宏分子架构提供了一种多功能方法.
- 该方法补充了现有的蛋白质结合和重组蛋白质表达技术.
相关概念视频
Protein Complexes with Interchangeable Parts
2.1K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.1K
Protein Complexes with Interchangeable Parts
1.0K
1.0K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Modified-Release Drug Delivery Systems: Stimuli-Activated
186
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
186
Receptor-mediated Endocytosis
105.5K
Overview
105.5K


